Current Atherosclerosis Reports

Papers
(The TQCC of Current Atherosclerosis Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Revascularization Options for Left Main Disease: What Clinicians Need to Know113
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?107
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes102
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions86
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management84
Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?64
A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment64
Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease63
Heart Transplant, Kawasaki Disease, and Bone Marrow Transplant: Are There Consequences?63
Watermelon and l-Citrulline in Cardio-Metabolic Health: Review of the Evidence 2000–202063
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis63
The Role of the PI3K/Akt/mTOR Pathway in Atherosclerosis: Mechanisms, Therapeutic Potential, and Emerging Targeted Treatments61
The Effects of FABP4 on Cardiovascular Disease in the Aging Population54
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management54
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?53
Salutary Effects of Nutritional Ketosis for the Diseased Human Heart50
Effects of Pioglitazone On Lipoprotein(a): A Meta-analysis50
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women46
Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event45
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice44
DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm44
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond41
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators39
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?37
The Emerging Specialty of Cardio-Rheumatology36
Recent Advances and Perspectives of Metabolomics-Based Investigations in Coronary Heart Disease35
The Role of Sleep in Cardiovascular Disease34
Programmable Genome-Editing Technologies as Single-Course Therapeutics for Atherosclerotic Cardiovascular Disease34
Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?34
Percutaneous Coronary Interventions in Women34
Correction to: Beta‑blockers for Atherosclerosis Prevention: a Missed Opportunity?34
Inflammation in the Peri-ACS Period: Ready for Prime Time?33
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women32
The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review31
GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?30
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention30
Myeloid Cells in Abdominal Aortic Aneurysm29
Lipoprotein(a): from Causality to Treatment28
Low LDL-C: Is It all Good News?28
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease27
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?26
Importance of Nutrition Security to CVD Prevention Efforts in the USA25
The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger25
Transgender Cardiovascular Health: Practical Management for the Clinician24
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know24
Childhood Hypertriglyceridemia: Is It Time for a New Approach?23
Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion23
Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis23
Update on Plant-Based Diets and Cardiometabolic Risk23
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment22
Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis22
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?21
Correction to: High-Density Lipoproteins and Serum Amyloid A (SAA)21
Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?20
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity20
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference20
Transforming Population Health Screening for Atherosclerotic Cardiovascular Disease with AI-Enhanced ECG Analytics: Opportunities and Challenges20
Evidence Gaps in Assessments of the Healthiness of Online Supermarkets Highlight the Need for New Monitoring Tools: a Systematic Review18
Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease18
Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction18
Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols18
SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor18
Dairy Foods: Is Its Cardiovascular Risk Profile Changing?18
Exploring the Role of SPARC in Atherosclerosis: Mechanisms and Potential Implications18
Is There a Role for Imaging Youth at Risk of Atherosclerosis?17
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?17
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?17
Cardiovascular Disease in the Middle East and North Africa, 1990–2021: Burden, Trends, and Risk Factors17
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference17
Clinical Management of Dyslipidemia in Infants and Toddlers16
HIV and Cardiovascular Disease Burden in Young Adults (18–25 years): A Review of Current Evidence16
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population16
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precision Medicine16
Cardiovascular Health and Disease in the Pakistani American Population16
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis16
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know16
Gene Regulatory Networks in Coronary Artery Disease16
Targeting the Gut Microbiome to Treat Cardiometabolic Disease15
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field15
What Causes Premature Coronary Artery Disease?15
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review15
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference15
Expanding Clinical Indications for Cardiac CT: A Review of Its Current Utility in American and European Guidelines15
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults15
Serial Coronary CTA for Monitoring Response to Lipid-Lowering Therapy: A Narrative Review14
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician14
The Role of Lysyl Oxidase in the Pathological Stage of Atherosclerosis: Structural Stabilizer or Disease Driver?14
Dietary Management of Atherogenic Dyslipidemia14
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms14
Bempedoic Acid: for Whom and When14
Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men14
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins14
Natural Sirtuin1 Activators and Atherosclerosis: an Overview14
Utility of FFRCT in Patients with Chest Pain14
Fixed Combination for the Treatment of Dyslipidaemia13
Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?13
Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments13
Circular RNA role in Atherosclerosis Development and Progression13
Correlation Between Oral Bacteria and Atherosclerotic Thrombotic Disease: Advances in Animal Model Studies13
0.089565992355347